Newsroom:Top News and Events
Exciting things are happening at NexImmune. Below you will find the latest news about our company, technology, pipeline and leadership.
FEBRUARY 06, 2024
NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Read More >
FEBRUARY 02, 2024
NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Read More >
OCTOBER 24, 2023
NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
Read More >